We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Novel Blood Test Differentiates Celiac from Gluten Sensitivity

By LabMedica International staff writers
Posted on 24 Nov 2017
The measurement of circulating cytokines in blood plasma within six hours of eating gluten differentiated patients with celiac disease from those with non-celiac gluten sensitivity.

Investigators found that a one-off oral gluten challenge caused an increase in interleukin (IL)-8, IL-10 and especially IL-2 in patients with celiac disease. More...
Conversely, patients with non-celiac gluten sensitivity showed no measurable immune response to gluten, but did show a symptom response to Fermentable, Oligo-, Di-, Mono-saccharides and Polyols (FODMAPs), specifically fructans.

Scientists at the University of Oslo (Norway) collaborating with those at ImmusanT (Cambridge, MA, USA) evaluated whether cytokine responses could distinguish between patients with celiac disease and non-celiac gluten sensitivity on a gluten-free diet. They evaluated IL-2, IL-8 and IL-10 plasma levels in 19 patients with celiac disease and 49 patients with non-celiac gluten sensitivity that underwent parallel food challenges. They drew blood samples before and 2, 4 and 6 hours after patients consumed breakfast bars containing gluten, FODMAP or placebo free of these ingredients.

Overall, the gluten-containing bars triggered mucosal changes in five of the patients with celiac disease, and induced a T-cell response in 12 of the 15 assessed. In contrast, the gluten-containing bars triggered no symptomatic response versus placebo in patients with non-celiac gluten sensitivity. Rather, these patients showed significantly higher irritable bowel syndrome symptom scores and bloating after consuming the FODMAP versus gluten bars. The team found that found that patients with celiac disease showed significant increases in IL-2 levels after consuming the gluten bars compared with non-celiac gluten sensitivity patients. At two hours the median elevations were 1.2-fold higher at four hours they were 10 times higher and at six hours they were 3.6 times higher.

Celiac patients also showed significantly higher increases in IL-8 and IL-10 relative to those with non-celiac gluten sensitivity at both four and six hours, but the median elevations were just between 1.2 to 1.8 times higher. Using optimized cutoffs, IL-2 identified celiac patients with 74% sensitivity and 98% specificity, while IL-8 performed with 42% sensitivity and 100% specificity, and IL-10 performed with 32% sensitivity and 100% specificity.

Robert P. Anderson, BMedSci, MB, ChB, PhD, FRACP, ImmusanT’s chief scientific officer, said, “It turns out that the people with celiac disease had an immune activation signature that we could measure in blood, and consistent with our previous study, this pointed to a T-cell effect, with gluten stimulating T-cells very quickly within 2 to 4 hours. But there was absolutely nothing that we could measure showing any form of immune activation in patients with non-celiac gluten sensitivity, which was surprising, because the immune activation in this condition is thought to be caused by the innate immune system releasing markers like IL-8.” The study was presented at the United European Gastroenterology Week 2017 held October 28 – November 1, in Barcelona, Spain.

Related Links:
University of Oslo
ImmusanT


New
Gold Member
Serological Pipets
INTEGRA Serological Pipets
Serological Pipet Controller
PIPETBOY GENIUS
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
New
Automated Microscope
dIFine
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: The RNA-seq based diagnostic test for pediatric leukemia ensures better outcomes for children with this common cancer (Photo courtesy of Qlucore)

RNA-Seq Based Diagnostic Test Enhances Diagnostic Accuracy of Pediatric Leukemia

A new unique test is set to reshape the way Acute Lymphoblastic Leukemia (BCP-ALL) samples can be analyzed. Qlucore (Lund, Sweden) has launched the first CE-marked RNA-seq based diagnostic test for pediatric... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.